The magnitude of each of these metabolic routes varies greatly between individual patients, while the influence (if any) of ifosfamide dose and schedule on its metabolism is unclear. [54,64 ...

The EICESS-92 trial compared the efficacy of cyclophosphamide and ifosfamide in patients with Ewing sarcoma. Subgroup analysis suggested that patients with large, localized tumors benefited from ...